The Canadian Breast Cancer Network exists to ensure the best quality of life for all Canadians diagnosed with breast cancer. We do this by voicing the views and concerns of breast cancer patients through education and advocacy activities. We also work to ensure that what we undertake is: patient-centered, credible and promotes equity.

Our latest digital magazine COVID-19 and Breast Cancer: Patient Voices, Expert Knowledge approaches the ongoing COVID-19 pandemic from the perspective of breast cancer patients and provides credible information for breast cancer patients from healthcare professionals and experts.

A breast cancer diagnosis comes with so many questions and there never seems to be enough time at appointments to have some of these questions answered. To help address this, we developed a "Q&E: Questions and Experts" series. In this series, a variety of experts spend the entire virtual session answering pre-submitted and live questions from participants. Watching the videos on-demand might be a little difficult to get through. So, we’ve created this guide to help you get right to the questions and answers that matter the most to you.

In today’s post, we provide the questions that were sent in and asked during the live session of our Questions and Experts session held in October 2021. In this session, Michele MacDonald, RPhT, a Regulated Pharmacy Technician a Drug Access Navigator, answered questions about accessing breast cancer drugs in Canada. In the parentheses, you’ll find the timestamp of where to find the question in the on-demand video.

In today’s post, we provide the questions that were sent in and asked during the live session of our Questions and Experts session held in September 2021. In this session, Dr. Dugald Seely, ND, a Naturopathic Doctor, answered questions about complementary therapies. In the parentheses, you’ll find the timestamp of where to find the question in the on-demand video.

In today’s post, we provide the questions that were sent in and asked during the live session of our Questions and Experts session held in May 2021. In this session, Dr. Mark Basik, MD, FRCPC, a Medical Oncologist, answered questions about breast cancer surgery. In the parentheses, you’ll find the timestamp of where to find the question in the on-demand video.

In today’s post, we provide the questions that were sent in and asked during the live session of our Questions and Experts session held in April 2021. In this session, Dr. Sandeep Sehdev, MD, FRCPC, a Medical Oncologist, answered questions about HR-positive breast cancer. In the parentheses, you’ll find the timestamp of where to find the question in the on-demand video.

While there have been many advances made in the diagnosing, treatment and management of breast cancer, individuals diagnosed with or living with breast cancer still face issues that are not yet being addressed by the organizations and government bodies that serve them. In addition to this, the public is generally not aware of the day-to-day impacts of a breast cancer diagnosis on individuals and their families.

In today’s post, we provide the questions that were sent in and asked during the live session of our Questions and Experts session held in April 2021. In this session, Dr. Karen Gelmon, MD, FRCPC, a Medical Oncologist, answered questions about HER2-positive breast cancer. In the parentheses, you’ll find the timestamp of where to find the question in the on-demand video.

Increasingly, the not-for-profit advocacy world has been questioned regarding industry funding. Many critics believe that any organization that receives funding from the pharmaceutical industry is automatically biased, but this ignores the great pains that health charities often go through to remain unbiased, ethical, and credible. And it certainly does not reflect the patient-centric approach that CBCN takes.